-
1
-
-
0033828271
-
Regulation of the differentiation and function of osteoclasts
-
Chambers, T. J. Regulation of the differentiation and function of osteoclasts. J. Pathol. 192, 4-13 (2000).
-
(2000)
J. Pathol.
, vol.192
, pp. 4-13
-
-
Chambers, T.J.1
-
2
-
-
0034284970
-
Bone resorption by osteoclasts
-
Teitlelbaum, S. L. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
-
(2000)
Science
, vol.289
, pp. 1504-1508
-
-
Teitlelbaum, S.L.1
-
3
-
-
0034284550
-
Therapeutic approaches to bone diseases
-
Rodan, G. A. & Martin, T. J. Therapeutic approaches to bone diseases. Science 289, 1508-1514 (2000).
-
(2000)
Science
, vol.289
, pp. 1508-1514
-
-
Rodan, G.A.1
Martin, T.J.2
-
4
-
-
0035206443
-
Minireview: The OPG/RANKL/RANK system
-
Khosla, S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142, 5050-5055 (2001).
-
(2001)
Endocrinology
, vol.142
, pp. 5050-5055
-
-
Khosla, S.1
-
5
-
-
0023928381
-
Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
-
Takahashi, N. et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122, 1373-1382 (1988).
-
(1988)
Endocrinology
, vol.122
, pp. 1373-1382
-
-
Takahashi, N.1
-
6
-
-
0032584208
-
Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
-
Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. USA 95, 3597-3602 (1998).
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 3597-3602
-
-
Yasuda, H.1
-
7
-
-
0032540319
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
-
Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (1998).
-
(1998)
Cell
, vol.93
, pp. 165-176
-
-
Lacey, D.L.1
-
8
-
-
0032545355
-
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
-
Nakagawa, N. et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun. 253, 395-400 (1998).
-
(1998)
Biochem. Biophys. Res. Commun.
, vol.253
, pp. 395-400
-
-
Nakagawa, N.1
-
9
-
-
13044316551
-
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
-
Hsu, H. et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl Acad. Sci. USA 96, 3540-3545 (1999).
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 3540-3545
-
-
Hsu, H.1
-
10
-
-
0033519221
-
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
-
Burgess, T. L. et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 145, 527-538 (1999).
-
(1999)
J. Cell Biol.
, vol.145
, pp. 527-538
-
-
Burgess, T.L.1
-
11
-
-
0032748995
-
Atp61-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification
-
Li, Y. P., Chen, W., Liang, Y., Li, E. & Stashenko, P. Atp61-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nature Genet. 23, 447-151 (1999).
-
(1999)
Nature Genet.
, vol.23
, pp. 447-1151
-
-
Li, Y.P.1
Chen, W.2
Liang, Y.3
Li, E.4
Stashenko, P.5
-
12
-
-
85047685623
-
TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL
-
Fuller, K., Murphy, C., Kirstein, B., Fox, S.W. & Chambers, T. J. TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143, 1108-1118 (2002).
-
(2002)
Endocrinology
, vol.143
, pp. 1108-1118
-
-
Fuller, K.1
Murphy, C.2
Kirstein, B.3
Fox, S.W.4
Chambers, T.J.5
-
14
-
-
0033168518
-
Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
-
Jimi, E. et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163, 434-442 (1999).
-
(1999)
J. Immunol.
, vol.163
, pp. 434-442
-
-
Jimi, E.1
-
15
-
-
0033888977
-
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
-
Lacey, D. L. et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am. J. Pathol. 157, 435-448 (2000).
-
(2000)
Am. J. Pathol.
, vol.157
, pp. 435-448
-
-
Lacey, D.L.1
-
16
-
-
0024429248
-
Osteoclast biology: Lessons from mammalian mutations
-
Marks, S. C. Jr Osteoclast biology: lessons from mammalian mutations. Am. J. Med. Genet. 34, 43-53 (1989).
-
(1989)
Am. J. Med. Genet.
, vol.34
, pp. 43-53
-
-
Marks Jr., S.C.1
-
17
-
-
0035478997
-
Mouse models of abnormal skeletal development and homeostasis
-
McLean, W. & Olsen, B. R. Mouse models of abnormal skeletal development and homeostasis. Trends Genet. 17, S38-S43 (2001).
-
(2001)
Trends Genet.
, vol.17
-
-
McLean, W.1
Olsen, B.R.2
-
18
-
-
0037195141
-
The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification
-
Van Wesenbeeck, L. et al. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc. Natl Acad. Sci. USA 99, 14303-14308 (2002).
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 14303-14308
-
-
Van Wesenbeeck, L.1
-
19
-
-
0036732410
-
SHIP-deficient mice are severely osteoporotic due to increased numbers of hyperresorptive osteoclasts
-
Takeshita, S. et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyperresorptive osteoclasts. Nature Med. 9, 943-949 (2002).
-
(2002)
Nature Med.
, vol.9
, pp. 943-949
-
-
Takeshita, S.1
-
20
-
-
0032079445
-
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
-
Bucay, N. et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268 (1998).
-
(1998)
Genes Dev.
, vol.12
, pp. 1260-1268
-
-
Bucay, N.1
-
22
-
-
0031005576
-
Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
-
Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319 (1997).
-
(1997)
Cell
, vol.89
, pp. 309-319
-
-
Simonet, W.S.1
-
23
-
-
0009660825
-
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
-
Yasuda, H. et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329-1337 (1998).
-
(1998)
Endocrinology
, vol.139
, pp. 1329-1337
-
-
Yasuda, H.1
-
25
-
-
14444272043
-
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells
-
Wong, B. R. et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190 (1997).
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 25190
-
-
Wong, B.R.1
-
26
-
-
0030714605
-
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
-
Anderson, D. M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179 (1997).
-
(1997)
Nature
, vol.390
, pp. 175-179
-
-
Anderson, D.M.1
-
27
-
-
12944262423
-
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
-
Li, J. et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl Acad. Sci. USA 97, 1566-1571 (2000).
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 1566-1571
-
-
Li, J.1
-
28
-
-
0033568341
-
RANK is essential for osteoclast and lymph node development
-
Dougall, W. C. et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424 (1999).
-
(1999)
Genes Dev.
, vol.13
, pp. 2412-2424
-
-
Dougall, W.C.1
-
29
-
-
0033611467
-
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis
-
Kong, Y. Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis. Nature 397, 315-323 (1999).
-
(1999)
Nature
, vol.397
, pp. 315-323
-
-
Kong, Y.Y.1
-
30
-
-
0033984313
-
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
-
Hofbauer, L. C. et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 15, 2-12 (2000).
-
(2000)
J. Bone Miner. Res.
, vol.15
, pp. 2-12
-
-
Hofbauer, L.C.1
-
31
-
-
0036218666
-
RANK-L and RANK: T cells, bone loss, and mammalian evolution
-
Theill, L. E., Boyle, W. J. & Penninger, J. M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795-823 (2002).
-
(2002)
Annu. Rev. Immunol.
, vol.20
, pp. 795-823
-
-
Theill, L.E.1
Boyle, W.J.2
Penninger, J.M.3
-
32
-
-
17744388339
-
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function
-
Udagawa, N. et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141, 3478-3484 (2000).
-
(2000)
Endocrinology
, vol.141
, pp. 3478-3484
-
-
Udagawa, N.1
-
33
-
-
0036120427
-
RANK ligand and osteoprotegerin: Paracrine regulators of bone metabolism and vascular function
-
Schoppet, M., Preissner, K. T. & Hofbauer, L. C. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler. Thromb. Vasc. Biol. 22, 549-553 (2002).
-
(2002)
Arterioscler. Thromb. Vasc. Biol.
, vol.22
, pp. 549-553
-
-
Schoppet, M.1
Preissner, K.T.2
Hofbauer, L.C.3
-
34
-
-
0032493737
-
Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase
-
Darnay, B. G., Haridas, V., Ni, J., Moore, P. A. & Aggarwal, B. B. Characterization of the intracellular domain of receptor activator of NF-κB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J. Biol Chem. 273, 20551-20555 (1998).
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 20551-20555
-
-
Darnay, B.G.1
Haridas, V.2
Ni, J.3
Moore, P.A.4
Aggarwal, B.B.5
-
35
-
-
0032545465
-
The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily
-
Galibert, L., Tometsko, M. E., Anderson, D. M., Cosman, D. & Dougall, W. C. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-κB, a member of the TNFR superfamily. J. Biol. Chem. 273, 34120-34127 (1998).
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 34120-34127
-
-
Galibert, L.1
Tometsko, M.E.2
Anderson, D.M.3
Cosman, D.4
Dougall, W.C.5
-
36
-
-
0033561039
-
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
-
Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024 (1999).
-
(1999)
Genes Dev.
, vol.13
, pp. 1015-1024
-
-
Lomaga, M.A.1
-
37
-
-
0035868884
-
Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis
-
Kobayashi, N. et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20, 1271-1280 (2001).
-
(2001)
EMBO J.
, vol.20
, pp. 1271-1280
-
-
Kobayashi, N.1
-
38
-
-
0037113931
-
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function
-
Armstrong, A. P. et al. A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J. Biol. Chem. 277, 44347-44356 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 44347-44356
-
-
Armstrong, A.P.1
-
39
-
-
18444390259
-
Distinct molecular mechanism for initiating TRAF6 signalling
-
Ye, H. et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447 (2002).
-
(2002)
Nature
, vol.418
, pp. 443-447
-
-
Ye, H.1
-
40
-
-
15444357762
-
Requirement for NF-κB in osteoclast and B-cell development
-
Franzoso, G. et al. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11, 3482-3496 (1997).
-
(1997)
Genes Dev.
, vol.11
, pp. 3482-3496
-
-
Franzoso, G.1
-
41
-
-
0036085510
-
NF-κB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis
-
Xing, L. et al. NF-κB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J. Bone Miner. Res. 17, 1200-1210 (2002).
-
(2002)
J. Bone Miner. Res.
, vol.17
, pp. 1200-1210
-
-
Xing, L.1
-
42
-
-
0028173214
-
c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling
-
Grigoriadis, A. E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443-448 (1994).
-
(1994)
Science
, vol.266
, pp. 443-448
-
-
Grigoriadis, A.E.1
-
43
-
-
0036546501
-
NF-κB in cancer: From an innocent bystander to major culprit
-
Karin, M., Cao, Y., Greten, F. R. & Li, Z.-W. NF-κB in cancer: from an innocent bystander to major culprit. Nature Rev. Cancer 2, 301-310 (2002).
-
(2002)
Nature Rev. Cancer
, vol.2
, pp. 301-310
-
-
Karin, M.1
Cao, Y.2
Greten, F.R.3
Li, Z.-W.4
-
44
-
-
0037113034
-
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation- dependent and -independent mechanisms
-
David, J. P., Sabapathy, K., Hoffmann, O., Idarraga, M. H. & Wagner, E. F. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation- dependent and -independent mechanisms. J. Cell Sci. 115, 4317-4325 (2002).
-
(2002)
J. Cell Sci.
, vol.115
, pp. 4317-4325
-
-
David, J.P.1
Sabapathy, K.2
Hoffmann, O.3
Idarraga, M.H.4
Wagner, E.F.5
-
45
-
-
0036023042
-
TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-κB
-
Lee, S. W., Han, S. I., Kim, H. H. & Lee, Z. H. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-κB. J. Biochem. Mol. Biol. 35, 371-376 (2002).
-
(2002)
J. Biochem. Mol. Biol.
, vol.35
, pp. 371-376
-
-
Lee, S.W.1
Han, S.I.2
Kim, H.H.3
Lee, Z.H.4
-
46
-
-
0036150184
-
Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6
-
Mizukami, J. et al. Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell. Biol. 22, 992-1000 (2002).
-
(2002)
Mol. Cell. Biol.
, vol.22
, pp. 992-1000
-
-
Mizukami, J.1
-
47
-
-
0036006406
-
Possible involvement of IκB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor κB ligand
-
Oda, H., Nakamura, K. & Tanaka, S. Possible involvement of IκB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor κB ligand. J. Bone Miner. Res. 17, 612-621 (2002).
-
(2002)
J. Bone Miner. Res.
, vol.17
, pp. 612-621
-
-
Oda, H.1
Nakamura, K.2
Tanaka, S.3
-
48
-
-
0036321005
-
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function
-
Li, X. et al. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143, 3105-3113 (2002).
-
(2002)
Endocrinology
, vol.143
, pp. 3105-3113
-
-
Li, X.1
-
49
-
-
0034613188
-
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)
-
Matsumoto, M., Sudo, T., Saito, T., Osada, H. & Tsujimoto, M. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL). J. Biol. Chem. 275, 31155-31161 (2000).
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 31155-31161
-
-
Matsumoto, M.1
Sudo, T.2
Saito, T.3
Osada, H.4
Tsujimoto, M.5
-
50
-
-
0037192784
-
Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-κB ligand signaling
-
Mansky, K. C., Sankar, U., Han, J. & Ostrowski, M. C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-κB ligand signaling. J. Biol. Chem. 277, 11077-11083 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 11077-11083
-
-
Mansky, K.C.1
Sankar, U.2
Han, J.3
Ostrowski, M.C.4
-
51
-
-
0037155165
-
Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and mitogen-activated protein kinase signaling
-
Wei, S., Wang, M. W., Teitelbaum, S. L. & Ross, F. P. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and mitogen-activated protein kinase signaling. J. Biol. Chem. 277, 6622-6630 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 6622-6630
-
-
Wei, S.1
Wang, M.W.2
Teitelbaum, S.L.3
Ross, F.P.4
-
52
-
-
0346525140
-
U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells
-
Hotokezaka, H. et al. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J. Biol. Chem. 277, 47366-47372 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 47366-47372
-
-
Hotokezaka, H.1
-
53
-
-
0033393957
-
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src
-
Wong, B. R. et al. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 4, 1041-1049 (1999).
-
(1999)
Mol. Cell
, vol.4
, pp. 1041-1049
-
-
Wong, B.R.1
-
54
-
-
0041663764
-
The immunosuppressant rapamycin, alone or with transforming growth factor-β, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand
-
Shui, C., Riggs, B. L. & Khosla, S. The immunosuppressant rapamycin, alone or with transforming growth factor-β, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand. Calcif. Tissue Int. 71, 437-446 (2002).
-
(2002)
Calcif. Tissue Int.
, vol.71
, pp. 437-446
-
-
Shui, C.1
Riggs, B.L.2
Khosla, S.3
-
55
-
-
0037077303
-
Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκB
-
Cappellen, D. et al. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκB. J. Biol. Chem. 277, 21971-21982 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 21971-21982
-
-
Cappellen, D.1
-
56
-
-
0037174944
-
Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator
-
Ishida, N. et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277, 41147-41156 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 41147-41156
-
-
Ishida, N.1
-
57
-
-
18744366041
-
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
-
Takayanagi, H. et al. Induction and activation of the transcription factor NFATc01 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002).
-
(2002)
Dev. Cell
, vol.3
, pp. 889-901
-
-
Takayanagi, H.1
-
58
-
-
0036233577
-
c-myc is required for osteoclast differentiation
-
Battaglino, R. et al. c-myc is required for osteoclast differentiation. J. Bone Miner. Res. 17, 763-773 (2002).
-
(2002)
J. Bone Miner. Res.
, vol.17
, pp. 763-773
-
-
Battaglino, R.1
-
59
-
-
0037158723
-
A block at the toll gate
-
Mak, T. W. & Yeh, W. C. A block at the toll gate. Nature 418, 835-836 (2002).
-
(2002)
Nature
, vol.418
, pp. 835-836
-
-
Mak, T.W.1
Yeh, W.C.2
-
60
-
-
0033398996
-
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors
-
Arai, F. et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J. Exp. Med. 190, 1741-1754 (1999).
-
(1999)
J. Exp. Med.
, vol.190
, pp. 1741-1754
-
-
Arai, F.1
-
61
-
-
0034835405
-
Regulation of osteoclastogenesis and RANK expression by TGF-β1
-
Yan, T., Riggs, B. L., Boyle, W. J. & Khosla, S. Regulation of osteoclastogenesis and RANK expression by TGF-β1. J. Cell. Biochem. 83, 320-325 (2001).
-
(2001)
J. Cell. Biochem.
, vol.83
, pp. 320-325
-
-
Yan, T.1
Riggs, B.L.2
Boyle, W.J.3
Khosla, S.4
-
62
-
-
0034878897
-
Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation
-
Ma, Y. L. et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142, 4047-4054 (2001).
-
(2001)
Endocrinology
, vol.142
, pp. 4047-4054
-
-
Ma, Y.L.1
-
63
-
-
0037129205
-
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
-
Takayanagi, H. et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416, 744-749 (2002).
-
(2002)
Nature
, vol.416
, pp. 744-749
-
-
Takayanagi, H.1
-
64
-
-
0037008742
-
Regulation of receptor activator of NF-κB ligand-induced osteoclastogenesis by endogenous interferon-β (INF-β) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs in IFN-β-inhibited osteoclast formation
-
Hayashi, T., Kaneda, T., Toyama, Y., Kumegawa, M. & Hakeda, Y. Regulation of receptor activator of NF-κB ligand-induced osteoclastogenesis by endogenous interferon-β (INF-β) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs in IFN-β-inhibited osteoclast formation. J. Biol. Chem. 277, 27880-27886 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 27880-27886
-
-
Hayashi, T.1
Kaneda, T.2
Toyama, Y.3
Kumegawa, M.4
Hakeda, Y.5
-
65
-
-
0034735773
-
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
-
Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408, 600-605 (2000).
-
(2000)
Nature
, vol.408
, pp. 600-605
-
-
Takayanagi, H.1
-
66
-
-
0033581952
-
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
-
Kong, Y. Y. et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304-309 (1999).
-
(1999)
Nature
, vol.402
, pp. 304-309
-
-
Kong, Y.Y.1
-
67
-
-
0037606007
-
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
-
in the press
-
Chagraoui, H. et al. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood (in the press).
-
Blood
-
-
Chagraoui, H.1
-
68
-
-
0033987358
-
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
-
Hughes, A. E. et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nature Genet. 24, 45-48 (2000).
-
(2000)
Nature Genet.
, vol.24
, pp. 45-48
-
-
Hughes, A.E.1
-
69
-
-
0036133351
-
Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis
-
Whyte, M. P. & Hughes, A. E. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J. Bone Miner. Res. 17, 26-29 (2002).
-
(2002)
J. Bone Miner. Res.
, vol.17
, pp. 26-29
-
-
Whyte, M.P.1
Hughes, A.E.2
-
70
-
-
0037130183
-
Osteoprotegerin deficiency and juvenile Paget's disease
-
Whyte, M. P. et al. Osteoprotegerin deficiency and juvenile Paget's disease. N. Engl. J. Med. 347, 175-184 (2002).
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 175-184
-
-
Whyte, M.P.1
-
71
-
-
18544371504
-
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype
-
Cundy, T. et al. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum. Mol. Genet. 11, 2119-2127 (2002).
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 2119-2127
-
-
Cundy, T.1
-
72
-
-
0035991255
-
Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures
-
Langdahl, B. L., Carstens, M., Stenkjaer, L. & Eriksen, E. F. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J. Bone Miner. Res. 17, 1245-1255 (2002).
-
(2002)
J. Bone Miner. Res.
, vol.17
, pp. 1245-1255
-
-
Langdahl, B.L.1
Carstens, M.2
Stenkjaer, L.3
Eriksen, E.F.4
-
73
-
-
0035139584
-
The effect of a single dose of osteoprotegerin in postmenopausal women
-
Bekker, P. J. et al. The effect of a single dose of osteoprotegerin in postmenopausal women. J. Bone Miner. Res. 16, 348-360 (2001).
-
(2001)
J. Bone Miner. Res.
, vol.16
, pp. 348-360
-
-
Bekker, P.J.1
-
74
-
-
0346837985
-
A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases
-
Body, J. J. et al. A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer97(Suppl.), 887-892 (2003).
-
(2003)
Cancer
, vol.97
, Issue.SUPPL.
, pp. 887-892
-
-
Body, J.J.1
-
75
-
-
0037398261
-
Role of RANK ligand in mediating the increased bone resorption in early postmenopausal women
-
Eghbali-Fatourechi, G. et al. Role of RANK ligand in mediating the increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221-1230 (2003).
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 1221-1230
-
-
Eghbali-Fatourechi, G.1
-
76
-
-
0037204816
-
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
-
Kim, Y. H., Kim, G. S. & Jeong-Hwa, B. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp. Mol. Med. 34, 145-151 (2002).
-
(2002)
Exp. Mol. Med.
, vol.34
, pp. 145-151
-
-
Kim, Y.H.1
Kim, G.S.2
Jeong-Hwa, B.3
-
77
-
-
18444379071
-
Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
-
Mizuno, A. et al. Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J. Bone Miner. Metab. 20, 337-344 (2002).
-
(2002)
J. Bone Miner. Metab.
, vol.20
, pp. 337-344
-
-
Mizuno, A.1
|